Pneumrx

 
 

Learn about our flagship product, PneumRx Coils, the body of clinical evidence, how to treat and how to refer patients for treatment. Coil therapy is now recognized in the GOLD COPD 2017 guidelines.

GOLD COPD
 
 
 

Clinical Evidence

The Coils have demonstrated safety and effectiveness in four European multi-center studies. A national randomized, controlled study in France is pending data release (early 2015). Enrollment for the FDA pivotal trial was completed in October 2014.

Learn More
 

How To Treat

From videos and workshops to proctoring and treatment planning guidelines, PneumRx supports you along your way to technical proficiency and successful incorporation of the Coil therapy into your emphysema management program. Our education program includes patient selection guidance, training for the bronchoscopy suite staff, and case proctoring.

Learn More
 

How To Refer

Primary care physicians and pulmonologists manage COPD patients using guideline-based care including smoking cessation, optimal medical management, pulmonary rehabilitation, and oxygen supplementation. But as dyspnea grows worse management strategies may expand to include endoscopic interventions to give patients symptomatic relief. PneumRx can help you develop effective screening strategies to refer patients likely to benefit from Coil treatment.

How To Refer